Species differences in ligand affinity at central A3‐adenosine receptors
- 1 September 1994
- journal article
- Published by Wiley in Drug Development Research
- Vol. 33 (1) , 51-59
- https://doi.org/10.1002/ddr.430330109
Abstract
Strategy, Management and Health Policy Venture Capital Enabling Technology Preclinical Research Preclinical Development Toxicology, Formulation Drug Delivery, Pharmacokinetics Clinical Development Phases I-III Regulatory, Quality, Manufacturing Postmarketing Phase IVKeywords
This publication has 28 references indexed in Scilit:
- BW-A522 blocks adenosine A3 receptor-mediated hypotensive responses in the ratEuropean Journal of Pharmacology, 1994
- Adenosine A3 receptors in mast cellsTrends in Pharmacological Sciences, 1994
- Molecular cloning and characterization of the human A3 adenosine receptor.Proceedings of the National Academy of Sciences, 1993
- Adenosine A3 receptors1 mediate hypotension in the angiotensin II-supported circulation of the pithed ratBritish Journal of Pharmacology, 1993
- Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.Proceedings of the National Academy of Sciences, 1992
- Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype.Molecular Endocrinology, 1992
- Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtypeMolecular Endocrinology, 1992
- RDC8 codes for an adenosine A2 receptor with physiological constitutive activityBiochemical and Biophysical Research Communications, 1990
- Adenosine A1 receptors in mammalian brain: Species differences in their interactions with agonists and antagonistsDrug Development Research, 1986
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973